Wednesday, March 26, 2014 1:16:20 PM
The funding from LPC made me think this scenario was likely. Going to Cavendish cements my thoughts on this. AMBS is seeking and able to get entrance to elite wealth. There is big money involved at Cavendish and more importantly, the type of people who can and do go in with their convictions. This is not like JP Morgan or Fidelity where the bottom line can get people fired if they make a bad bet. Visionaries bet on visionaries.
The main thing is that if AMBS can score big with Lympro on their own then they can afford to control a lot more of MANF and Phenoguard.
I am waiting patiently to see how this unfolds. Go AMBS!
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM